The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Effects of Tadalafil on Erectile Dysfunction in Men With Diabetes
Abstract
OBJECTIVE—To evaluate the efficacy and safety of tadalafil taken as needed before sexual activity by men with diabetes and erectile dysfunction (ED). RESEARCH DESIGN AND METHODS—Men with type 1 or type 2 diabetes and a minimum 3-month history of ED were randomly allocated to one of three groups: placebo (n = 71), tadalafil 10 mg (n = 73), or tadalafil 20 mg (n = 72) taken up to once daily for 12 weeks. Changes from baseline in mean scores on the erectile function domain of the International Index of Erectile Function (IIEF) and changes from baseline in the proportion of “yes” responses to question 2, “Were you able to penetrate?,” and 3, “Were you able to complete intercourse?,” of the Sexual Encounter Profile were coprimary outcome measures. RESULTS—A total of 191 (88%) of 216 patients completed the study. Treatment with tadalafil significantly improved all primary efficacy variables, regardless of baseline HbA1c level. Therapy with tadalafil also significantly improved a number of secondary outcome measures, including changes in other IIEF domains, individual IIEF questions, and percentage of positive responses to a global assessment question measuring erection improvement. Treatment with tadalafil did not alter mean HbA1c levels. Tadalafil was well tolerated, with headache and dyspepsia being the most frequent adverse events with active treatment. CONCLUSIONS—Tadalafil therapy significantly enhanced erectile function and was well tolerated by men with diabetes and ED.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GAQ revealed that only 25% of men in the placebo group felt they had improved erections, compared with 56% and 64% of men in the tadalafil 10 mg and 20 mg groups, respectively (p < 0.001) (Sáenz de Tejada et al 2002).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Sáenz de Tejada et al 2002
In the citing paper
“Successful intercourse was improved by 28% and 29% in the two tadalafil groups versus only 1.9% in the placebo group (p < 0.001).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Sáenz de Tejada et al 2002
In the citing paper
“In the largest original, prospective trial of tadalafil in diabetic men, Sáenz de Tejada and co-workers reported that tadalafil significantly improves ED and is well tolerated in this population (Sáenz de Tejada et al 2002).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Sáenz de Tejada et al 2002
In the citing paper
“In diabetic men taking tadalafil 10 mg or 20 mg, the IIEF-EF was improved by 6.4 and 7.3, respectively, compared with 0.1 with placebo (p < 0.001) (Sáenz de Tejada et al 2002).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Sáenz de Tejada et al 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
(1999) · doi:10.1016/s0090-4295(99)00099-0 · Cited by 1,051
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Research works printed but not linked: 18
- Metro MJ, Broderick GA: Diabetes and vascular impotence: does insulin dependence increase the relative severity? Int J Impot Res 11: 87–89, 1999 · DOI
- Lehman TP, Jacobs JA: Etiology of diabetic impotence. J Urol 129:291–294, 1983 · DOI
- Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ: Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 19:135–141, 1996 · DOI
- Buvat J, Lemaire A, Buvat-Herbaut M, Fourlinnie JC, Racadot A, Fossati P: Hyperprolactinemia and sexual function in men. Horm Res 22:196–203, 1985 · DOI
- McCulloch DK, Young RJ, Prescott RJ, Campbell IW, Clarke BF: The natural history of impotence in diabetic men. Diabetologia 26:437–440, 1984 · DOI
- McKinlay JB: The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 12 (Suppl. 4):S6–S11, 2000 · DOI · Paper page
- Aytac IA, McKinlay JB, Krane RJ: The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 84:50–56, 1999 · DOI · Paper page
- Rendell MS, Rajfer J, Wicker PA, Smith MD: Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial: Sildenafil Diabetes Study Group. JAMA 281:421–426, 1999 · DOI
- Price DE, Gingell JC, Gepi-Attee S, Wareham K, Yates P, Boolell M: Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabet Med 15:821–825, 1998 · DOI
- Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J: Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 170:843–850, 1990 · DOI · Paper page
- Burnett AL: Nitric oxide in the penis: physiology and pathology. J Urol 157:320–324, 1997 · DOI
- Sáenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025–1030, 1989 · DOI
- Padma-Nathan H, McMurray JG, Pullman WE, Whitaker JS, Saoud JB, Ferguson KM, Rosen RC: On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 13:2–9, 2001 · DOI
- Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile function. Urology 49:822–830, 1997 · DOI · Paper page
- Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C: Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50:1016–1026, 1997 · DOI
- Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 163:460–463, 2000 · DOI · Paper page
- Tanner FC, Noll G, Boulanger CM, Luscher TF: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation 83:2012–2020, 1991 · DOI · Paper page
- Rosenfeld ME: Oxidized LDL affects multiple atherogenic cellular responses. Circulation 83:2137–2140, 1991 · DOI
Cited by
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Tadalafil pharmacokinetics in healthy subjects
Forgue, S. T., Patterson, B. E., Bedding, A. W., Payne, C. D., Phillips, D. L., Wrishko, R. E., & Mitchell, M. I. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02553.x · Cited by 284
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Tadalafil: a novel treatment for erectile dysfunction
GIULIANO, F. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90049-0 · Cited by 21
Metadata
- Authors
- Sáenz de Tejada, I., Anglin, G., Knight, J. R., & Emmick, J. T.
- Affiliations
- Fundacíon para la Investigacíon y el Desarrollo en Andrología, Madrid, Spain
- Eli Lilly Canada, Toronto, Ontario, Canada
- Eli Lilly and Company, Indianapolis, Indiana
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-12-01
- Volume
- 25
- Issue
- 12
- Pages
- 2159-2164
- ISSN
- 0149-5992
- 1935-5548
- Cited by
- 195
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
